ZAURITO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 184
AS - Asia 81
NA - Nord America 79
SA - Sud America 6
AF - Africa 3
Totale 353
Nazione #
RU - Federazione Russa 129
US - Stati Uniti d'America 72
IT - Italia 28
SG - Singapore 22
CN - Cina 15
HK - Hong Kong 15
BD - Bangladesh 13
VN - Vietnam 10
GB - Regno Unito 7
BR - Brasile 4
DE - Germania 4
MX - Messico 4
CA - Canada 3
FR - Francia 3
ZA - Sudafrica 3
ES - Italia 2
FI - Finlandia 2
IN - India 2
PL - Polonia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CO - Colombia 1
JP - Giappone 1
LV - Lettonia 1
NL - Olanda 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 353
Città #
San Jose 16
Hong Kong 15
Moscow 15
New York 11
Singapore 11
Milan 10
Ashburn 9
Dallas 6
Rome 4
Buffalo 3
Council Bluffs 3
Hanoi 3
Ho Chi Minh City 3
Santa Clara 3
Beijing 2
Chongqing 2
Da Nang 2
Denver 2
Göttingen 2
Hefei 2
Johannesburg 2
Lari 2
Mexico City 2
Montreal 2
Orem 2
Poplar 2
Warsaw 2
Abu Dhabi 1
Apodaca 1
Barnet 1
Bexley 1
Bila Tserkva 1
Bắc Ninh 1
Calgary 1
Champlin 1
Chicago 1
City of London 1
Cosenza 1
El Pueblito 1
Emalahleni 1
Falkenstein 1
Frankfurt am Main 1
Gothenburg 1
Haiphong 1
Honolulu 1
Houston 1
Kirov 1
La Rioja 1
Lappeenranta 1
Lauterbourg 1
Los Angeles 1
L’Aquila 1
Manassas 1
Mumbai 1
Naples 1
North Bergen 1
Pasto 1
Pescara 1
Riga 1
Riyadh 1
Saquarema 1
Staten Island 1
Stavropol 1
Stockholm 1
Suqian 1
Surat 1
São Carlos 1
São Luís de Montes Belos 1
Tashkent 1
Tokyo 1
Turin 1
Turku 1
Valencia 1
Volta Redonda 1
Zurich 1
Totale 186
Nome #
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 112
DNA methylation alterations in prostate cancer: from diagnosis to treatment 99
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 69
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 66
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 9
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 4
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challenge 4
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials 4
Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials”(European Urology, (2025), (S0302283825048778), 10.1016/j.eururo.2025.12.022) 4
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancer 3
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer 2
Totale 376
Categoria #
all - tutte 1.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251 0 0 0 0 0 0 0 0 0 0 0 1
2025/2026375 17 13 8 24 33 15 21 50 112 25 34 23
Totale 376